Fri, Oct 31, 2014, 3:03 AM EDT - U.S. Markets open in 6 hrs 27 mins


% | $
Quotes you view appear here for quick access.

Serologicals Corp. (SERO) Message Board

  • damienpmoore damienpmoore Feb 27, 2001 1:32 PM Flag

    industry sector

    NABI , a competitor, posted earnings yesterday that confirm the strong marketplace for specialty antibodies...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thanks for the insight info! Hopefully, we
      will all be smiling by Friday.

    • Thanks for the post re NABI. I strongly recommend that all interested in Sero read this new release. Several observations that relate to Sero;
      1)At current price of NABI @ $5 5/16, P/E @ 12 cents is 44x TTM EPS (WOW!);
      2) "improved performance" was clearly noted;
      3) A 2% decrease in revenues is of concern;
      4) Operating margins increased "significantly";
      5) 2001 outlook... "double digit" revenue growth is expected if product supply is not interrupted...partially as a result of higher pricing;
      6) Further improvement in margins is expected;
      While I'm disappointed in the recent setback in Sero's stock price, consider Sero's real value if NABI sells at 44 times TTM EPS and experienced flat revenue growth in 2000. This analysis gave me further evidence of Sero's potential share value for those who do not panic and have the patience to wait, or the cash to buy more shares at these prices. Good luck to all. What a buying opportunity for Sero, and many other great companies! FoFo.


Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.